Moderna Recovers From 10% Dive, But Muted Expectations Haunt Cancer Vaccine

Moderna stock yo-yoed Monday on more muted expectations for its Merck-partnered cancer vaccine, INT. The post Moderna Recovers From 10% Dive, But Muted Expectations Haunt Cancer Vaccine appeared first on Investor's Business Daily.